An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)
Clinical trial NCT05879614 · WITHDRAWN
Trial details
- NCT number
- NCT05879614
- Sponsor
- Neuren Pharmaceuticals Limited
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-06-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.